Andrew Mok
Stock Analyst at Barclays
(3.56)
# 889
Out of 5,116 analysts
245
Total ratings
58.08%
Success rate
2.46%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Overweight | $87 → $93 | $79.61 | +16.82% | 12 | Dec 10, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Equal-Weight | $17 → $14 | $14.69 | -4.70% | 19 | Dec 4, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $245 → $234 | $258.83 | -9.59% | 14 | Nov 25, 2025 | |
| ASTH Astrana Health | Maintains: Equal-Weight | $36 → $26 | $25.41 | +2.32% | 2 | Nov 24, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $229 → $240 | $200.60 | +19.64% | 16 | Nov 21, 2025 | |
| SGRY Surgery Partners | Maintains: Equal-Weight | $24 → $18 | $15.87 | +13.42% | 5 | Nov 21, 2025 | |
| RDNT RadNet | Maintains: Overweight | $79 → $86 | $73.15 | +17.57% | 9 | Nov 13, 2025 | |
| BKD Brookdale Senior Living | Upgrades: Overweight | $9.5 → $14 | $10.89 | +28.56% | 1 | Nov 11, 2025 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $22 → $23 | $24.13 | -4.68% | 10 | Nov 10, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $11 → $13 | $14.91 | -12.81% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $1.5 → $1 | $0.73 | +37.78% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $35 → $44 | $40.51 | +8.62% | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $111 → $117 | $110.16 | +6.21% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $383 → $300 | $276.51 | +8.50% | 9 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $18.78 | -4.15% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $141 → $150 | $107.52 | +39.51% | 18 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $149 → $143 | $113.98 | +25.46% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $250 → $263 | $227.64 | +15.53% | 25 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $495 → $525 | $477.13 | +10.03% | 15 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $185 → $144 | $164.84 | -12.64% | 10 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $395 → $385 | $349.88 | +10.04% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $352 → $386 | $331.83 | +16.32% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5.5 → $9.5 | $8.62 | +10.21% | 2 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.23 | +8.36% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $9.38 | +27.93% | 1 | Dec 8, 2022 |
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $87 → $93
Current: $79.61
Upside: +16.82%
Acadia Healthcare Company
Dec 4, 2025
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $14.69
Upside: -4.70%
Humana
Nov 25, 2025
Maintains: Equal-Weight
Price Target: $245 → $234
Current: $258.83
Upside: -9.59%
Astrana Health
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $25.41
Upside: +2.32%
Tenet Healthcare
Nov 21, 2025
Maintains: Overweight
Price Target: $229 → $240
Current: $200.60
Upside: +19.64%
Surgery Partners
Nov 21, 2025
Maintains: Equal-Weight
Price Target: $24 → $18
Current: $15.87
Upside: +13.42%
RadNet
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $73.15
Upside: +17.57%
Brookdale Senior Living
Nov 11, 2025
Upgrades: Overweight
Price Target: $9.5 → $14
Current: $10.89
Upside: +28.56%
Privia Health Group
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $24.13
Upside: -4.68%
Oscar Health
Nov 10, 2025
Maintains: Underweight
Price Target: $11 → $13
Current: $14.91
Upside: -12.81%
Nov 6, 2025
Maintains: Underweight
Price Target: $1.5 → $1
Current: $0.73
Upside: +37.78%
Nov 4, 2025
Maintains: Equal-Weight
Price Target: $35 → $44
Current: $40.51
Upside: +8.62%
Nov 4, 2025
Maintains: Underweight
Price Target: $111 → $117
Current: $110.16
Upside: +6.21%
Nov 3, 2025
Maintains: Overweight
Price Target: $383 → $300
Current: $276.51
Upside: +8.50%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $18.78
Upside: -4.15%
Oct 30, 2025
Maintains: Overweight
Price Target: $141 → $150
Current: $107.52
Upside: +39.51%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $149 → $143
Current: $113.98
Upside: +25.46%
Oct 28, 2025
Maintains: Overweight
Price Target: $250 → $263
Current: $227.64
Upside: +15.53%
Oct 27, 2025
Maintains: Buy
Price Target: $495 → $525
Current: $477.13
Upside: +10.03%
Oct 24, 2025
Downgrades: Underweight
Price Target: $185 → $144
Current: $164.84
Upside: -12.64%
Oct 22, 2025
Maintains: Overweight
Price Target: $395 → $385
Current: $349.88
Upside: +10.04%
Oct 9, 2025
Maintains: Overweight
Price Target: $352 → $386
Current: $331.83
Upside: +16.32%
Aug 19, 2025
Upgrades: Overweight
Price Target: $5.5 → $9.5
Current: $8.62
Upside: +10.21%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.23
Upside: +8.36%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $9.38
Upside: +27.93%